SCHEMBL31662771

SCHEMBL31662771

COCCNCCNC(=O)OCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
HTT P42858 1/20 0.57
L3MBTL1 Q9Y468 3/20 0.56
MAPT P10636 1/20 0.55
TGM2 P21980 1/20 0.51
KEAP1 Q14145 2/20 0.50
NFE2L2 Q16236 2/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 2/20 0.48
SLC1A3 P43003 1/20 0.48
SLC1A1 P43005 1/20 0.48
KDM4E B2RXH2 1/20 0.48
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5063193 0.91 LMNA (0.77) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL5019074 0.89 LMNA (0.73) LMNASMN1; SMN2HTTL3MBTL1MAPT
Hydrochloric Acid SCHEMBL4506331 0.88 LMNA (0.71) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL22166825 0.85 HTT (0.68) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL21338348 0.85 LMNA (0.63) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL14985738 0.85 LMNA (0.63) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL31420909 0.85 LMNA (0.59) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL10243339 0.85 LMNA (0.71) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL13055383 0.84 LMNA (0.80) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL6645232 0.84 HTT (0.67) LMNASMN1; SMN2HTTL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151449-A1 BIFUNCTIONAL P53-BINDING COMPOUNDS AND USES THEREOF PHOTYS THERAPEUTICS, INC. (US) 2025-07-17 WO disclosed